Management of established coronary artery disease in aircrew with previous myocardial infarction or revascularisation

Eddie D. Davenport, Thomas Syburra, Gary Gray, Rienk Rienks, Dennis Bron, Olivier Manen, Joanna D'Arcy, Norbert J. Guettler, Edward D. Nicol*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


This manuscript focuses on the broad aviation medicine considerations that are required to optimally manage aircrew with established coronary artery disease (CAD) without myocardial infarction (MI) or revascularisation (both pilots and non-pilot aviation professionals). It presents expert consensus opinion and associated recommendations and is part of a series of expert consensus documents covering all aspects of aviation cardiology. Aircrew may present with MI (both ST elevation MI (STEMI) and non-ST elevation MI (NSTEMI)) as the initial presenting symptom of obstructive CAD requiring revascularisation. Management of these individuals should be conducted according to published guidelines, ideally with consultation between the cardiologist, surgeon and aviation medical examiner. Return to restricted flight duties is possible in the majority of aircrew; however, they must have normal cardiac function, acceptable residual disease burden and no residual ischaemia. They must also be treated with aggressive cardiac risk factor modification. Aircrew should be restricted to dual pilot operations in non-high-performance aircraft, with return to flying no sooner than 6 months after the event. At minimum, annual follow-up with routine non-invasive cardiac evaluation is recommended.

Original languageEnglish
Pages (from-to)S31-S37
StatePublished - 1 Jan 2019
Externally publishedYes


  • aviation medicine
  • cardiology


Dive into the research topics of 'Management of established coronary artery disease in aircrew with previous myocardial infarction or revascularisation'. Together they form a unique fingerprint.

Cite this